Recombinant human fibrinogen expressed in the yeast Pichia pastoris was assembled and biologically active

Protein Expression and Purification

Volumn 59, Issue 2, 2008, Pages 289-296

  Tojo, Naoko ^a   Miyagi, Ikuko ^a   Miura, Masami ^a   Ohi, Hideyuki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Assembly; Biologically active; Recombinant human fibrinogen; Yeast Pichia pastoris

Indexed keywords

FIBRINOGEN; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; CULTURE TECHNIQUE; GENE VECTOR; GENETICS; HUMAN; PH; PICHIA;

CELL CULTURE TECHNIQUES; FIBRINOGEN; GENETIC VECTORS; HUMANS; HYDROGEN-ION CONCENTRATION; PICHIA; RECOMBINANT PROTEINS;

PICHIA PASTORIS;

EID: 42749089626     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.02.010     Document Type: Article

References (51)

1. Rixon M.W., Chan W.Y., Davie E.W., and Chang D.W. Characterization of a complementary deoxynucleic acid coding for the α chain of human fibrinogen. Biochemistry 22 (1983) 3237-3244
2. Chang D.W., Que B.G., Rixon M.W., Mace Jr. M., and Davie E.W. Characterization of a complementary deoxynucleic acid and genomic deoxyribonucleic acid for the β chain of human fibrinogen. Biochemistry 22 (1983) 3244-3250
3. Chang D.W., Chan W.Y., and Davie E.W. Characterization of a complementary deoxyribonucleic acid coding for the γ chain of human fibrinogen. Biochemistry 22 (1983) 3250-3256
4. Chang D.W., Harris J.E., and Davie E.W. Nucleotide sequence of the three genes coding for human fibrinogen. Adv. Exp. Med. Biol. 281 (1991) 39-48
5. Henschen A., Lottspeich F., Kehl M., and Southan M.C. Covalent structure of fibrinogen. Ann. NY Acad. Sci. 408 (1983) 28-43
6. Townsend R.R., Hilliker E., Li Y.T., Laine R.A., Bell W.R., and Lee Y.C. Carbohydrate structure of human fibrinogen. J. Biol. Chem. 257 (1982) 9704-9710
7. Nossel H.L., Hurlet-Jansen A., Liu C.Y., Koehn J.A., and Canfield R.E. Fibrinopeptide release from fibrinogen. Ann. NY Acad. Sci. 408 (1983) 269-278
8. Hantgan R., McDonagh J., and Hermans J. Fibrin assembly. Ann. NY Acad. Sci. 408 (1983) 344-366
9. Tock B., Drohan W., Hess J., Pusateri A., Holcomb J., and MacPhee M. Haemophilia and advanced fibrin sealant technologies. Haemophilia 4 (1998) 449-455
10. Albara D.M. Fibrin sealants in clinical practice. Cardiovasc. Surg. 1 (2003) 5-11
11. Spotnitz W.D., and Prabhu R. Fibrin sealant tissue adhesive-review and update. J. Long Term Eff. Med. Implants 15 (2005) 245-270
12. Tredwell S., Jackson J.K., Hamilton D., Lee V., and Burt H.M. Use of fibrin sealants for the localized, controlled release of cefazolin. Can. J. Surg. 49 (2006) 347-352
13. Farrell D.H., Mulvihill E.R., Huang S., Chung D.W., and Davie E.W. Recombinant human fibrinogen and sulfation of γ′ chain. Biochemistry 30 (1991) 9414-9420
14. Huang S., Mulvihill E.R., Farrell D.H., Chung D.W., and Davie E.W. Biosynthesis of human fibrinogen. J. Biol. Chem. 268 (1993) 8919-8926
15. Huang S., Cao Z., Chung D.W., and Davie E.W. The role of βγ and αγ complexes in the assembly of human fibrinogen. J. Biol. Chem. 271 (1996) 27942-27947
16. Xu W.F., Chung D.W., and Davie E.W. The assembly of human fibrinogen. J. Biol. Chem. 271 (1996) 27948-27953
17. Binnie C.G., Hettasch J.M., Strickland E., and Lord S.T. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A. Biochemistry 32 (1993) 107-113
18. Lord S.T., Binnie C.G., Hettasch J.M., and Strickland E. Purification and characterization of recombinant human fibrinogen. Blood Coagul. Fibrinolysis 4 (1993) 55-59
19. Gorkun O.V., Veklich Y.I., Weisel J.W., and Lord S.T. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood 89 (1997) 4407-4414
20. Prunkard D., Cottingham I., Garner I., Bruce S., Dalrymple M., Lasser G., Bishop P., and Foster D. High-level expression of recombinant human fibrinogen in the milk of transgenic mice. Nat. Biotechnol. 14 (1996) 867-871
21. Butler S.P., Cott K.V., Subrumanian A., Gwazduaskas F.C., and Velander W.H. Current progress in production of recombinant human fibrinogen in the milk of transgenic animals. Thromb. Haemost. 78 (1997) 537-542
22. Lubon H. Transgenic animal bioreactors in biotechnology and production of blood proteins. Biotechnol. Annu. Rev. 4 (1998) 1-54
23. Butler S.P., O'Sickey T.K., Load S.T., Lubon H., Gwazduaskas F.C., and Velander W.H. Secretion of recombinant human fibrinogen by the murine mammary gland. Transgenic Res. 13 (2004) 437-450
24. Bolyard M.G., and Load S.T. High-level expression of a functional human fibrinogen gamma chain in Escherichia coli. Gene 66 (1988) 183-192
25. Bolyard M.G., and Load S.T. Expression in Escherichia coli of the human fibrinogen Bβ chain and its cleavage by thrombin. Blood 73 (1989) 1202-1206
26. Load S.T., and Fowlkes D.M. Expression of a fibrinogen fusion peptide in Escherichia coli: a model thrombin substrate for structure/function analysis. Blood 73 (1989) 166-171
27. 420 contain calcium binding sites but lack polymerization pockets. Blood 92 (1998) 3669-3674
28. E C domain of human fibrinogen-420 is a stable and early plasmin cleavage product. Blood 95 (2000) 2297-2303
29. Kruse K.B., Dear A., Kaltenbrun E.R., Crum B.E., George P.M., Brennan S.O., and McCracken A.A. Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy. Am. J. Pathol. 168 (2006) 1299-1308
30. Farrell D.H., Huang S., and Davie E.W. Processing of the carboxyl 15-amino acid extension in the α-chain of fibrinogen. J. Biol. Chem. 268 (1993) 10351-10355
31. Fowlkes D.M., Mullis N.T., Comeau C.M., and Crabtree G.R. Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5′ flanking regions. Proc. Natl. Acad. Sci. USA 81 (1984) 2313-2316
32. Huber P., Dalmon J., Courtois G., Laurent M., Assouline Z., and Marguerie G. Characterization of the 5′-flanking region for the human fibrinogen β gene. Nucleic Acids Res. 15 (1987) 1615-1625
33. Ohi H., Miura M., Hiramatsu R., and Ohmura T. The positive and negative cis-acting elements for methanol regulation in the Pichia pastoris AOX2 gene. Mol. Gen. Genet. 243 (1994) 489-499
34. Ito H., Fukuda Y., Murata K., and Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153 (1983) 163-168
35. Tarentino A.L., Gomez C.M., and Plummer Jr. T.H. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase. Biochemistry 24 (1985) 4665
36. Brankamp R.G., Sreekrishna K., Smith P.L., Blankenship D.T., and Cardin A.D. Expression of a synthetic gene encoding the anticoagulant-antimetastatic protein ghilanten by the methylotrophic yeast Pichia pastoris. J. Protein Expr. Purif. 6 (1995) 813-820
37. McKee P.A., Mattock P., and Hill R.L. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc. Natl. Acad. Sci. USA 66 3 (1970) 738-744
38. Lorand L. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma. Ann. NY Acad. Sci. 202 (1972) 6-30
39. Kanaide H., and Shainoff J.R. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J. Lab. Clin. Med. 85 (1975) 574-597
40. Mosesson M.W., and Siebenlist K.R. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J. Struct. Biol. 115 (1995) 88-101
41. Collet J.P., Moen J.L., Veklich Y.I., Gorkun O.V., Lord S.T., Montalescot G., and Weisel J.W. The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood 106 (2005) 3824-3830
42. Huang S., Cao Z., Chang D.W., and Davie E.W. The role of βγ and αγ complexes in the assembly of human fibrinogen. J. Biol. Chem. 271 (1996) 27942-27947
43. Zhang J.Z., and Redman C. Fibrinogen assembly and secretion. J. Biol. Chem. 271 (1996) 30083-30088
44. Redman C.M., and Xia H. A review of the expression, assembly, secretion and intracellular degradation of fibrinogen. Fibrinolysis 14 (2000) 198-205
45. Redman C.M., and Xia H. Fibrinogen biosynthesis, assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann. NY Acad. Sci. 936 (2001) 480-495
46. Cregg J.M., Cereghino L.L., Shi J., and Higgins D.R. Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16 (2000) 23-52
47. Weiss H.M., Haase W., Michel H., and Reilander H. Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett. 377 (1995) 451-456
48. +-ATPase in Pichia pastoris. J. Biol. Chem. 278 (2003) 46064-46073
49. Tsujikawa M., Okabayashi K., Morita M., and Tanabe T. Secretion of a variant of human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of secretion product. Yeast 12 (1996) 541-553
50. Nishibe H., and Takahashi N. The release of carbohydrate moieties from human fibrinogen by almond glycopeptidase without alteration in fibrinogen clottability. Biochim. Biophys. Acta 661 (1981) 274-279
51. Gralnick H.R., Givelber H., and Abrams E. Disfibrinogenemia associated with hepatoma: increased carbohydrate content of the fibrinogen molecule. N. Engl. J. Med. 299 (1978) 221-226